Verastem Oncology (VSTM) Misses Q1 EPS by 43c
Get Alerts VSTM Hot Sheet
Join SI Premium – FREE
Verastem Oncology (NASDAQ: VSTM) reported Q1 EPS of ($0.43). Revenue for the quarter came in at $18.67 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share